Revolution Medicines, Inc. - stock earnings
RVMD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -161.5 million USD | 742000 USD |
| 2023Q3 | -108.4 million USD | ? USD |
| 2023Q2 | -98.3 million USD | 3.8 million USD |
| 2023Q1 | -58.5 million USD | 7.0 million USD |
| 2022Q4 | -56.5 million USD | 15.3 million USD |
| 2022Q3 | -73.3 million USD | 3.4 million USD |
| 2022Q2 | -60.4 million USD | 9.1 million USD |
| 2022Q1 | -57.3 million USD | 7.6 million USD |
| 2021Q4 | -52.7 million USD | 9.5 million USD |
| 2021Q3 | -52.9 million USD | 1.1 million USD |
| 2021Q2 | -44.3 million USD | 8.7 million USD |
| 2021Q1 | -37.2 million USD | 10.1 million USD |
| 2020Q4 | -34.2 million USD | 8.8 million USD |
| 2020Q3 | -27.2 million USD | 12.7 million USD |
| 2020Q2 | -27.2 million USD | 10.0 million USD |
| 2020Q1 | -19.5 million USD | 11.5 million USD |
| 2019Q4 | -14.6 million USD | 12.1 million USD |
| 2019Q3 | -12.8 million USD | 12.5 million USD |
| 2019Q2 | -10.1 million USD | 12.3 million USD |
| 2019Q1 | -10.1 million USD | 13.2 million USD |
| 2018Q4 | -11.3 million USD | 10.3 million USD |
| 2018Q3 | -30.5 million USD | 9.8 million USD |
RVMD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -436.4 million USD | 11.6 million USD |
| 2022 | -248.7 million USD | 35.4 million USD |
| 2021 | -179.8 million USD | 29.4 million USD |
| 2020 | -108.2 million USD | 43.0 million USD |
| 2019 | -47.7 million USD | 50.0 million USD |
| 2018 | -41.8 million USD | 20.2 million USD |
| 2017 | -31.1 million USD | ? USD |
RVMD
Price: $37.28
52 week price:
Earnings Per Share: -3.86 USD
P/E Ratio: -9.17
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 856800
Market Capitalization: 5.9 billion